肺癌治疗:个性化医学的作用
Raquel Ramos1,2,3, Conceição Souto Moura4, Mariana Costa3
1PerMed Research Group, RISE-Health, Faculty of Medicine, University of Porto, Alameda Professor Hernâni Monteiro, 4200-319 Porto, Portugal.
Cancers
|March 13, 2025
概括
肺癌是癌症死亡的主要原因,需要个性化医疗. 下一代测序 (NGS) 识别非小细胞肺癌的突变,指导向疗法并改善患者的治疗结果.
科学领域:
- 在瘤学瘤学.
- 基因组学就是基因组学.
- 个性化医疗是个性化的医疗.
背景情况:
- 肺癌是全球癌症相关死亡的主要原因,通常由于非特异性症状而在晚期被诊断出来.
- 治疗决定对患者的生存至关重要,并取决于组织学类型和瘤遗传学.
- 非小细胞肺癌 (NSCLC) 是最常见的类型,具有很高的突变负担,需要先进的诊断工具.
研究的目的:
- 审查目前针对不同类型肺癌的治疗策略.
- 介绍肺癌治疗中的新兴疗法和新药开发.
- 强调个性化医疗在优化肺癌护理和患者生活质量的重要性.
主要方法:
- 审查目前的临床指导方针和肺癌治疗方法.
- 分析分子分析的最新进展,包括下一代测序 (NGS).
- 综合新兴向治疗的数据和个性化肺癌治疗的持续研究.
主要成果:
- 下一代测序 (NGS) 对于识别非小细胞肺癌 (NSCLC) 的可操作突变至关重要.
- 已经批准了几种向疗法,证明了个性化医学的肺癌疗效.
- 目前正在进行的研究重点是开发针对特定患者和瘤特征量身定制的新个性化治疗方法.
结论:
- 以分子分析为指导的个性化医学正在改变肺癌治疗模式.
- 基于基因突变的定制疗法显著提高了肺癌患者的生存率和生活质量.
- 对新兴治疗方法的持续研究有望在治疗这种致命疾病方面取得进一步进展.
更多相关视频
07:59Author Spotlight: Advancements in Molecular Biomarker Testing for Non-Squamous Non-Small Cell Lung Cancer
Published on: September 8, 2023
996
10:29Semi-automatic PD-L1 Characterization and Enumeration of Circulating Tumor Cells from Non-small Cell Lung Cancer Patients by Immunofluorescence
Published on: August 14, 2019
10.5K
相关概念视频
Combination Therapies and Personalized Medicine
4.8K
Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
4.8K
Targeted Cancer Therapies
7.4K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
7.4K
Cancer Therapies
7.5K
Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
7.5K
Cancer
47.3K
Cancers arise due to mutations in genes involved in the regulation of cell division, which leads to unrestricted cell proliferation. Modern science and medicine have made great strides in the understanding and treatment of cancer, including eradicating cancer in some patients. However, there is still no cure for cancer. This is largely due to the fact that cancer is a large group of many diseases.
47.3K
Tumor Immunotherapy
457
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
457
